کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5555285 1559740 2017 5 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Ginsenoside Rg1 attenuates the inflammatory response in DSS-induced mice colitis
موضوعات مرتبط
علوم زیستی و بیوفناوری ایمنی شناسی و میکروب شناسی ایمونولوژی
پیش نمایش صفحه اول مقاله
Ginsenoside Rg1 attenuates the inflammatory response in DSS-induced mice colitis
چکیده انگلیسی


- Ginsenoside Rg1 inhibits DSS-induced proinflammatory cytokines release.
- Ginsenoside Rg1 up-regulates NLRP12 expression during DSS stimulation.
- Ginsenoside Rg1 ameliorates mice clinical symptoms via regulating NLRP12 expression.

Ginsenoside Rg1 is a major active constituent of Panax ginseng and possesses anti-inflammatory effects. It has been reported to have therapeutic effects on various diseases. In the present study, we investigated the role of ginsenoside Rg1 in dextran sodium sulfate (DSS)-induced mouse colitis. Our results showed that ginsenoside Rg1 markedly reduces proinflammatory cytokines release upon DSS stimulation of mouse dendritic cells, that ginsenoside Rg1 suppresses IL-1β (Interleukin 1 beta) and TNF-α (Tumor necrosis factor alpha) release via up-regulation of NLRP12 (NACHT, LRR and PYD domains-containing protein 12) expression, and that ginsenoside Rg1 significantly decreases the inflammatory response to DSS-induced mouse colitis, as evidenced by increased body weight, reduced colonic damage scores and disease activity index (DAI), and lowered proinflammatory cytokines levels. These results highlight the potential therapeutic use of ginsenoside Rg1 as an anti-inflammatory agent in the treatment of colitis.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: International Immunopharmacology - Volume 50, September 2017, Pages 1-5
نویسندگان
, , , ,